The parents of a 31-year-old woman with epilepsy who died after allegedly following ChatGPT advice to reduce her medication filed suit against OpenAI on Friday, seeking damages and new safeguards on medical guidance. The San Francisco-based artificial intelligence company now faces one of the first U.S. wrongful-death actions tied directly to health advice generated by a consumer AI product.

The woman died after cutting her anti-seizure dosage, which her family's attorneys said was prompted by interactions with the chatbot. Legal analysts expect the case to test the limits of platform liability for health guidance provided by AI systems.

OpenAI has previously said its models are not intended to provide medical diagnosis or treatment and include disclaimers directing users to consult clinicians. The lawsuit argues those warnings were insufficient given the specificity of the advice the woman allegedly received, according to the complaint.

The suit comes as regulators and physicians groups, including the American Medical Association, have urged tighter controls on AI tools dispensing health information. The AMA has called for clearer labeling and clinician oversight of medical content delivered through general-purpose chatbots.

Consumer-safety advocates said the case could reshape how AI firms handle health queries, potentially forcing hard limits on dosing and medication guidance across the industry.